Background
Intima-media thickness (IMT) measured on ultrasound images of the common carotid artery (CCA) is associated with cardiovascular risk factors and events. Given the physics of ultrasound, CCA far wall IMT measurements are favored over near wall measurements, but this theoretical advantage is not well studied.
Methods
A total of 6,606 members of the Multi-Ethnic Study of Atherosclerosis, a longitudinal cohort study (mean age, 62.1 years; 52.7% women) who had near wall and far wall CCA IMT measurements. Multivariate linear regression models were used to estimate model goodness of fit of Framingham risk factors with near wall IMT, far wall IMT, and combined mean IMT. Multivariate Cox proportional hazards models were used to estimate hazard ratios for incident coronary heart disease events for each IMT variable. Change in Harrell’s C statistic was used to compare the incremental value of each IMT variable when added to Framingham risk factors.
Results
Mean IMT had the strongest association with risk factors ( R 2 = 0.31), followed by near wall ( R 2 = 0.26) and far wall ( R 2 = 0.22) IMT. Far wall IMT improved the prediction of coronary artery disease events over the Framingham risk factors (change in C statistic, 0.012; 95% CI, 0.006–0.017; P < .001), as did mean IMT ( P = .004), but near wall IMT did not.
Conclusions
Far wall CCA IMT showed the strongest association with incident coronary heart disease, whereas mean IMT had the strongest associations with risk factors. This difference might affect the selection of appropriate IMT variables in different studies.
Carotid intima-media thickness (IMT) has been defined as the distance between the lumen-intima and the media-adventitia interfaces seen on ultrasound images of the common carotid artery (CCA) wall.
The IMT measurement can be made on the wall nearest to the ultrasound transducer (near wall) as well as on the wall that is farthest from the transducer (far wall). It has been argued that the near wall IMT measurement might not be reliable, because of the physics of ultrasound imaging. Although it is true that cardiovascular disease (CVD) outcomes are associated with far wall IMT measurements, it is also true that this association holds for measurements combining the near and far wall IMT. With respect to cardiovascular outcomes, there is no clear-cut evidence of an advantage to either approach.
Intervention trials that use carotid IMT as an outcome tend to combine near and far wall measurements. This seems to improve the reliability of the measurements. At least one epidemiologic study has suggested that this approach strengthens the association between risk factors and IMT.
We hypothesized that combining near and far wall IMT of the CCA would improve the associations of IMT with risk factors and with coronary artery disease outcomes. We studied these two hypotheses in the Multi-Ethnic Study of Atherosclerosis (MESA), a multiethnic cohort.
Methods
Population
MESA comprises a multiethnic population of 6,814 men and women aged 45 to 84 years enrolled between July 2000 and August 2002 at six sites in the United States. The MESA cohort includes white, African American, Hispanic, and Chinese participants. Participants were excluded if they had physician diagnoses of myocardial infarction (MI), stroke, transient ischemic attack, heart failure, angina, or atrial fibrillation; histories of any cardiovascular procedure; weight > 300 lb; pregnancy; or any medical conditions that would prevent long-term participation. MESA protocols and all studies described herein have been approved by the institutional review boards of all collaborating institutions, and all participants gave informed consent.
Risk Factors and Anthropomorphic Variables
Age, sex, race/ethnicity, and medical history as well as medication use were self-reported. Current smoking was defined as self-report of one or more cigarettes in the past 30 days. Resting systolic and diastolic blood pressures were measured three times in the seated position using a Dinamap Pro 100 automated oscillometric sphygmomanometer (Critikon, Tampa, FL); the average of the last two measurements was used in these analyses.
Glucose and lipids were measured after a 12-hour fast. Serum glucose was measured by rate-reflectance spectrophotometry on the Vitros analyzer (Johnson & Johnson Clinical Diagnostics, Inc, Rochester, NY). Diabetes mellitus was determined according to the 2003 American Diabetes Association fasting criteria. Total cholesterol was measured using a cholesterol oxidase method (Roche Diagnostics GmbH, Mannheim, Germany), as was high-density lipoprotein (HDL) after precipitation of non-HDL cholesterol with magnesium/dextran.
The Framingham risk factors used in the analyses are the original risk factors determined for coronary heart disease (CHD) events (including angina) as reported by Wilson et al . : age, systolic blood pressure, total cholesterol, HDL cholesterol, smoking history, and diabetes, to which we added sex and race/ethnicity. We used the risk factors rather than calculated risk scores to circumvent calibration problems due to the diverse ethnic composition of our cohort. We also added use of blood pressure–lowering medication as part of the augmented Framingham risk score for CVD proposed by D’Agostino et al . in a sensitivity analysis.
Carotid Artery Measures
The results of the CCA measurements are part of a comprehensive protocol that acquired videotaped images from both sides of the neck and included imaging of the distal CCA (one view on each side) and the proximal internal carotid artery and bulb (three projections on each side). Details of the carotid artery evaluation have previously been described, and the acquisition protocol is the same one used in the Cardiovascular Health Study. The participants were imaged in the supine position with the head rotated 45° away from the side being imaged. The CCA was imaged with the beginning of the bulb shown on the image (to the left). A matrix-array probe (M12L; GE Medical Systems, Waukesha, WI) was used with the frequency set at 13 MHz, with two focal zones and a frame rate of 32 frames/sec.
All carotid artery measurements were blinded and made at the ultrasound reading center at Tufts Medical Center (Boston, MA). Videotapes were reviewed, and images were selected from a short cine recording lasting a few seconds. The readers were instructed to capture (digitize) a CCA image for IMT measurement such that the artery lumen had the smallest diameter during the cardiac cycle, the near and far walls had clear interfaces, and there was minimal degradation due to motion. Near and far wall common carotid IMT measurements were made of each CCA (one projection) using hand-drawn continuous tracings of the intima-lumen and media-adventitia interfaces ( Figure 1 ) that were processed with a previously described algorithm.
Far wall IMT was the mean of the far wall IMT of both the right and left common carotid arteries. Similarly, near wall IMT was the mean of the near wall IMT of both the right and left common carotid arteries. The mean IMT was the mean of all four CCA IMT values.
Outcomes
Events were identified during follow-up examinations and by telephone interview conducted every 9 to 12 months to inquire about all interim hospital admissions, cardiovascular outpatient diagnoses, and deaths. Copies were obtained of all death certificates and of all medical records for hospitalizations and outpatient cardiovascular diagnoses. The review process included all generated International Classification of Diseases, Ninth Revision, definitions, but the final adjudication of MESA end points was based on specific criteria applied to data obtained from medical records by two committee members or by the whole-study events committee in case of disagreement.
CHD events included MI, death due to CHD, resuscitated cardiac arrest, definite or probable angina followed by coronary revascularization, and definite angina not followed by coronary revascularization. Cases of coronary artery revascularization that did not have concurrent diagnoses of angina were not included, to minimize possible referral bias. “Hard” CVD events included MI, resuscitated cardiac event, stroke, and death due to CHD or stroke.
The diagnosis of MI was based on a combination of symptoms, electrocardiographic findings, and circulating cardiac biomarkers. Death was considered related to CHD if it occurred <28 days after a myocardial infarct, if the participant had experienced chest pain within the 72 hours preceding death, or if the participant had a history of CHD and died without documentation of any other cause of death. Resuscitated cardiac arrest included participants who successfully recovered from full cardiac arrest through cardiopulmonary resuscitation. Adjudicators graded the presence of angina on the basis of the following criteria: definite or probable angina required clear and definite documentation of symptoms without the development of MI. Definite angina also required objective evidence of reversible myocardial ischemia or obstructive coronary artery disease. Stroke was defined as a documented new-onset neurologic event lasting >24 hours or until death if death occurred in the first 24 hours.
Statistical Analyses
The mean (and SD) and median (and interquartile range) values of continuous variables and the percentage distribution of dichotomous variables as a percentage in each group are shown for the participants. We calculated the individual near and far wall IMT measurements for each individual and reported the difference as a mean and SD as well as median and interquartile range.
Reproducibility was assessed in two ways: (1) repeat image acquisitions and (2) the rereading of already acquired imaging studies. Blinded replicate scans were performed on 150 participants. Because of blinding, the same readers read most of the 150 repeat studies (144 of the 150 studies). Blinded rereads of 155 studies were also performed. The same readers (intrareader variability) read 78 of these cases and different readers (interreader variability) the remaining 77 cases. Reproducibility was calculated as Pearson correlation coefficients and 95% CIs.
Multivariate linear regression models were created with three separate outcomes: near wall IMT, far wall IMT, and mean IMT. The original Framingham risk factors were used as independent variables with the addition of race/ethnicity.
The main outcome was time to first CHD event. A baseline multivariate Cox proportional hazards model using robust error handling was created with the components of the Framingham risk score: age, systolic blood pressure, diabetes, HDL cholesterol, total cholesterol, and smoking, to which we added sex and race/ethnicity. To this model was added each of the three IMT metrics as continuous variables to create three new models for the estimation of hazard ratios (HRs). We used standardized values for systolic blood pressure, total and HDL cholesterol, as well as the IMT metrics to facilitate comparisons of the hazards ratios. Harrell’s C statistics were obtained for all of the Cox proportional hazards models. The predictive value of each model with a given IMT measurement was compared with the baseline model using the differences in Harrell’s C statistic. The proportional hazards assumption was verified using Schoenfeld residuals. Net reclassification improvement and incremental discrimination improvement were calculated as described by Pencina et al . Net reclassification improvement was calculated form the Framingham cut points of 6% and 20% at 10 years.
Kaplan-Meier curves were generated for illustrative purposes using unadjusted quartiles of near wall, far wall, and combined near and far wall IMT.
We performed a sensitivity analysis by using the difference between near wall and far wall IMT as a variable in the multivariate Cox proportional hazards models adjusted for risk factors, sex, and race/ethnicity. We also evaluated the predictive power of IMT measurements for incident “hard” CVD events in a sensitivity analysis.
Statistical analyses were performed using Stata version 11.2 (StataCorp LP, College Station, TX). The level of statistical significance was set at P ≤ .05. Net reclassification improvement and incremental discrimination improvement were calculated with the help of a Stata add-on from the Uppsala Clinical Research Center ( http://www.ucr.uu.se/en/index.php/epistat/program-code/306-nri-and-idi ).
Results
Of the original 6,814 MESA participants, 6,739 underwent ultrasound examinations at baseline. Near wall measurements were obtained in 6,667 individuals and far wall IMT in 6,722. Complete far wall and near wall IMT measurements were made in 6,663 individuals. We excluded another 52 individuals because of missing risk factors and five with prevalent CHD not detected at the first examination, for a final study population of 6,606.
There were 484 CHD events, of which 209 were angina events, during a median 11.2 years (interquartile range, 10.6–11.7 years) of follow-up. Table 1 summarizes the characteristics of the population studied. The average age was 62.1 years, and 47.3% of the population was male. The racial/ethnic breakdown was as follows: 38.8% white, 12.0% Chinese, 27.2% black, and 22.0% Hispanic participants. The mean systolic blood pressure was 126.5 ± 21.5 mm Hg, the mean HDL cholesterol level was 50.9 ± 14.8 mg/dL, and the mean total cholesterol level was 194.1 ± 35.6 mg/dL. The prevalence of diabetes was 14.0%, and 12.9% of participants were current smokers. The mean difference between near and far wall IMT values was 0.047 ± 0.197 mm, the near wall IMT being larger ( P < .0001).
Variable | Value | Median (interquartile range) |
---|---|---|
Age (y) | 62.1 ± 10.2 | 62 (53 to 70) |
Sex (men) | 3,123/6,606 (47.3%) | — |
Race/ethnicity | ||
White | 2,564/6,606 (38.8%) | — |
Chinese | 792/6,606 (12.0%) | — |
African American | 1,795/6,606 (27.2%) | — |
Hispanic | 1,455/6,606 (22.0%) | — |
Diabetes (yes) | 923/6,606 (14.0%) | — |
Smoker (yes) | 855/6,606 (12.9%) | — |
Blood pressure–lowering medication (yes) | 2,424/6,606 (36.7%) | |
Systolic blood pressure (mm Hg) | 126.5 ± 21.5 | 123.5 (111 to 139.5) |
HDL cholesterol (mg/dL) | 50.9 ± 14.8 | 48.0 (40 to 59) |
Total cholesterol (mg/dL) | 194.1 ± 35.6 | 192 (170 to 215) |
Mean near wall IMT (mm) | 0.79 ± 0.19 | 0.76 (0.66 to 1.03) |
Mean far wall IMT (mm) | 0.74 ± 0.21 | 0.71 (0.60 to 0.84) |
Mean near and far wall IMT (mm) | 0.76 ± 0.18 | 0.74 (0.64 to 0.86) |
Difference between near and far wall IMT (mm) | 0.047 ± 0.197 | 0.06 (−0.05 to 0.15) |
Number of CHD events | 484/6,606 (7.3%) | — |
Number of “hard” CVD events | 477/6,606 (7.2%) | — |
For replicate image acquisitions, correlation coefficients were stronger for far wall IMT ( r = 0.92; 95% CI, 0.88–0.94) and mean IMT ( r = 0.91; 95% CI, 0.87–0.93) than for near wall IMT ( r = 0.80; 95% CI, 0.73–0.85). Intrareader variability was high and similar for far wall IMT ( r = 0.96; 95% CI, 0.94–0.98), near wall IMT ( r = 0.97; 95% CI, 0.94–0.98), and mean IMT ( r = 0.97; 95% CI, 0.96–0.98). Interreader variability was consistently lower than intrareader variability at r = 0.79 (95% CI, 0.69–0.86) for far wall IMT, r = 0.84 (95% CI, 0.75–0.89) for near wall IMT, and r = 0.82 (95% CI, 0.73–0.88) for mean IMT.
Cross-Sectional Associations of Risk Factors with IMT
Results of the multivariate linear regression models are shown in Table 2 . All risk factors were significantly associated with the individual IMT measurements with the exception of current smoking. The respective coefficients for age, systolic blood pressure, HDL cholesterol, and diabetes in the three models were similar. Despite remaining significant in all cases, the standardized coefficients for total cholesterol varied from 0.037 for each change of 1 mm in near wall IMT to 0.055 for far wall IMT. Differences in the coefficients were also notable for sex, increasing from 0.03 for a change of 1 mm in near wall IMT to 0.045 for far wall IMT. Racial/ethnic differences were present, with Chinese participants having lower IMT values than whites and blacks having larger IMT values than whites. Overall, the best goodness of fit for risk factors was for mean IMT ( R 2 = 0.31), followed by near wall IMT ( R 2 = 0.26) and then far wall IMT ( R 2 = 0.22).
Variable | Mean near wall IMT | Mean far wall IMT | Mean of near and far wall IMT | |||
---|---|---|---|---|---|---|
β | P | β | P | β | P | |
Age | 0.007 | <.001 | 0.007 | <.001 | 0.007 | <.001 |
Sex (male) | 0.030 | <.001 | 0.045 | <.001 | 0.038 | <.001 |
Race/ethnicity | ||||||
White (referent) | ||||||
Chinese | −0.044 | <.001 | −0.021 | .004 | −0.033 | <.001 |
African American | 0.055 | <.001 | 0.024 | <.001 | 0.039 | <.001 |
Hispanic | −0.002 | .69 | −0.008 | .19 | −0.006 | .25 |
Diabetes (yes) | 0.036 | <.001 | 0.034 | <.001 | 0.035 | <.001 |
Smoker (yes) | 0.011 | .07 | 0.0003 | .97 | 0.006 | .30 |
Systolic blood pressure ∗ | 0.134 | <.001 | 0.161 | <.001 | 0.170 | <.001 |
HDL cholesterol ∗ | −0.075 | <.001 | −0.084 | <.001 | −0.090 | <.001 |
Total cholesterol ∗ | 0.037 | <.001 | 0.055 | <.001 | 0.054 | <.001 |
Model goodness of fit ( R 2 ) | 0.26 | <.0001 | 0.22 | <.0001 | 0.31 | <.0001 |
∗ Standardized values for coefficients: units of 21.5 mm Hg for systolic blood pressure, 35.6 mg/dL for total cholesterol, and 14.8 mg/dL for HDL cholesterol.
Longitudinal Prediction of CHD Events by IMT
Results of Kaplan-Meir failure curves are plotted by quartile of IMT values in Figure 2 A for near wall IMT, Figure 2 B for far wall IMT, and Figure 2 C for mean IMT. Results for the multivariate Cox proportional hazards model that included all risk factors are shown to the left of Table 3 . Important predictors of CVD were increasing age, male sex, current smoking, increasing systolic blood pressure, presence of diabetes, lower HDL cholesterol, and elevated total cholesterol. There was a tendency for whites to have stronger associations with CHD than other ethnicities. The HR for near wall IMT was not significant (1.01; 95% CI, 0.92–1.11) for each increase of 0.19 mm, whereas the HRs for mean IMT (1.17; 95% CI, 1.08–1.28) and far wall IMT (1.21; 95% CI, 1.13–1.30) were significant for respective increases of 0.21 and 0.18 mm.
Variables | Risk factors | Risk factors and near wall IMT | Risk factors and far wall IMT | Risk factors and mean of the far wall and near wall IMT | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
HR | Lower 95% CL | Upper 95% CL | HR | Lower 95% CL | Upper 95% CL | HR | Lower 95% CL | Upper 95% CL | HR | Lower 95% CL | Upper 95% CL | |
Age | 1.05 | 1.04 | 1.06 | 1.05 | 1.04 | 1.06 | 1.04 | 1.03 | 1.05 | 1.04 | 1.03 | 1.06 |
Sex (male) | 2.06 | 1.68 | 2.54 | 2.06 | 1.67 | 2.54 | 1.97 | 1.60 | 2.43 | 1.98 | 1.61 | 2.45 |
Race/ethnicity | ||||||||||||
White (referent) | — | — | — | — | — | — | — | — | — | — | — | — |
Chinese | 0.58 | 0.41 | 0.80 | 0.58 | 0.41 | 0.80 | 0.59 | 0.42 | 0.82 | 0.60 | 0.43 | 0.83 |
African American | 0.78 | 0.62 | 0.99 | 0.78 | 0.62 | 0.99 | 0.78 | 0.62 | 0.98 | 0.76 | 0.61 | 0.96 |
Hispanic | 0.77 | 0.61 | 0.98 | 0.77 | 0.61 | 0.98 | 0.79 | 0.62 | 1.00 | 0.78 | 0.61 | 0.99 |
Diabetes (yes) | 1.85 | 1.49 | 2.30 | 1.85 | 1.49 | 2.30 | 1.79 | 1.44 | 2.22 | 1.79 | 1.44 | 2.22 |
Smoker (yes) | 1.66 | 1.29 | 2.14 | 1.66 | 1.28 | 2.14 | 1.65 | 1.28 | 2.12 | 1.64 | 1.27 | 2.11 |
Systolic blood pressure ∗ | 1.29 | 1.18 | 1.41 | 1.29 | 1.18 | 1.41 | 1.24 | 1.14 | 1.36 | 1.25 | 1.14 | 1.37 |
HDL cholesterol ∗ | 0.85 | 0.76 | 0.95 | 0.85 | 0.76 | 0.95 | 0.86 | 0.76 | 0.96 | 0.86 | 0.76 | 0.96 |
Total cholesterol ∗ | 1.14 | 1.04 | 1.25 | 1.14 | 1.04 | 1.25 | 1.13 | 1.03 | 1.25 | 1.14 | 1.03 | 1.25 |
IMT ∗ | 1.01 † | 0.92 | 1.11 | 1.21 | 1.13 | 1.30 | 1.17 | 1.08 | 1.28 |